Cogent Biosciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANAB
|
AnaptysBio, Inc. | $22.26 | $640.07 M | -3.82 | 117 | $17.16 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 IDYA
|
IDEAYA Biosciences, Inc. | $26.78 | $2.88 B | -19 | 124 | $23.39 M |
 KALV
|
KalVista Pharmaceuticals, Inc. | $10.16 | $492.76 M | -3.74 | 150 | $0 |
 KNSA
|
Kiniksa Pharmaceuticals, Ltd. | $21.26 | $1.35 B | 146.62 | 297 | $270.26 M |
 KROS
|
Keros Therapeutics, Inc. | $55.91 | $1.76 B | -9.45 | 160 | $151,000 |
 KURA
|
Kura Oncology, Inc. | $10.79 | $1.66 B | -10.03 | 142 | $0 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.16 | $611.84 M | -9.99 | 42 | $0 |
 MGTX
|
MeiraGTx Holdings plc | $5.93 | $306.74 M | -4.01 | 387 | $14.02 M |
 MRSN
|
Mersana Therapeutics, Inc. | $2.04 | $261.85 M | -1.91 | 123 | $36.86 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $8.78 | $734.41 M | -6.56 | 74 | $0 |
 PTGX
|
Protagonist Therapeutics, Inc. | $46.45 | $2.04 B | 13.7 | 126 | $60.00 M |
 SANA
|
Sana Biotechnology, Inc. | $2.60 | $1.55 B | -4.59 | 328 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $16.09 | $1.66 B | -6.02 | 184 | $0 |
 VRNA
|
Verona Pharma plc | $38.78 | $983.52 M | -15.16 | 79 | $0 |
 VTYX
|
Ventyx Biosciences, Inc. | $1.85 | $229.83 M | -1.01 | 75 | $0 |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.23 | $754.16 M | -3.26 | 124 | $0 |